.svg)
CIO Bulletin
| Company | Management | Description |
|---|---|---|
| Asymchem Group | Dr. Hao Hong CEO Chairman |
Asymchem is proud of the strides that it has made since its founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving success is its commitment to continual optimization and investing in the future. |
| PreClinical Safety (PCS) Consultants Ltd. | Dr. med. vet. Stephanie Plassmann Senior expert in non-clinical drug development |
PCS Consultants is the right partner who is offering exactly what drug companies need. They provide independent expert advisory services, pharmacological and non-clinical safety evaluations to the pharmaceutical, agro-chemical, chemical, and food industries, academic institutions engaged in science and research, and to business investors and CROs. |
| Minoryx Therapeutics | Marc Martinell PhD, CEO & Co-Founder |
Minoryx is a clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. |
| Alvotech | Mark Levick CEO |
Alvotech's mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. |
| Clinevo Technologies | Mani Vasudevan Ph.D. CEO |
Clinevo Technologies is an IT Services and Software Development Company specialized in developing and implementing robust technology solutions for Life Sciences domain. It helps Pharma, Biotech and CROs in reducing their time and cost in Clinical trials by implementing innovative technologies. |
| EpiEndo Pharmaceuticals | Maria Bech MSc CEO |
EpiEndo Pharmaceuticals is an Icelandic clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as a common mechanism of many inflammatory conditions such as the airway, gastrointestinal tract and skin. |
| AFYX Therapeutics | Lars Siim Madsen PH.D. CEO |
AFYX Therapeutics is changing the way mucosal diseases are treated. The company is developing a pipeline of targeted treatments for unmet medical needs in oral health diseases, such as Head and Neck cancer and Oral Lichen Planus; and women’s health diseases, such as Vulvar Sclerosus." |
| HiFiBiO Therapeutics | Liang Schweizer Ph.D. Founder Chairperson & CEO |
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. |
| Real Life Sciences | Elliot Zimmerman CEO |
Real Life Sciences supports regulated organizations in sharing clinical data while meeting regulatory disclosure requirements and develops novel Real World Evidence via Social Media Epidemiology. |
| Oculis S.A. | Riad Sherif MD CEO |
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the lives of patients worldwide. |
Banking-and-finance
Artificial-intelligence
Travel-and-hospitality
Management-consulting
Banking-and-finance
Banking-and-finance
Food-and-beverage
Travel-and-hospitality
Food-and-beverage
 consultants ltd.jpg)
.jpg)
